Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time to Raise the Bar to Psoriasis Area Severity Index 90 and 100.

× No keyword cloud information.

6 in total

Review 1. Remicade^® (infliximab): 20 years of contributions to science and medicine.

Authors: Richard Melsheimer; Anja Geldhof; Isabel Apaolaza; Thomas Schaible
Journal: Biologics Date: 2019-07-30

2. Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI response.

Authors: Laura M Sawyer; Kinga Malottki; Celia Sabry-Grant; Najeeda Yasmeen; Emily Wright; Anne Sohrt; Emma Borg; Richard B Warren
Journal: PLoS One Date: 2019-08-14 Impact factor: 3.240

3. Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.

Authors: P C M van de Kerkhof; R Loewe; U Mrowietz; M Falques; I Pau-Charles; J C Szepietowski
Journal: J Eur Acad Dermatol Venereol Date: 2019-10-17 Impact factor: 6.166

4. A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate-to-severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO-BIO-REAL).

Authors: J Seneschal; J-P Lacour; A Bewley; M Faurby; C Paul; G Pellacani; C De Simone; L Horne; A Sohrt; M Augustin; E Hammond; K Reich
Journal: J Eur Acad Dermatol Venereol Date: 2020-06-08 Impact factor: 6.166

5. Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL).

Authors: Jean-Philippe Lacour; Anthony Bewley; Edward Hammond; Jes B Hansen; Laura Horne; Carle Paul; Kristian Reich; Julien Seneschal; Clara De Simone; Anne Sohrt; Matthias Augustin; Giovanni Pellacani
Journal: Dermatol Ther (Heidelb) Date: 2020-08-06

6. Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.

Authors: Boni E Elewski; Andrew Blauvelt; Gaia Gallo; Eric Wolf; Missy McKean-Matthews; Russel Burge; Joseph F Merola; Alice B Gottlieb; Lyn C Guenther
Journal: Dermatol Ther (Heidelb) Date: 2022-03-13